ISSN: 2278-0238

薬学および生命科学における研究開発の国際ジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Unlocking Novel Therapies: Drug Discovery through Pharmacoinformatics

Dr. Mika Adinath

In the dynamic landscape of drug discovery, where innovation and efficiency are paramount, the integration of advanced technologies has revolutionized the process. One such game-changer is Pharmacoinformatics-a discipline that harnesses the power of computational methods and data analysis to expedite the identification and development of new therapeutic agents. In this article, we delve into the world of drug discovery through pharmacoinformatics, exploring its significance, methodologies, and the transformative impact it holds for the pharmaceutical industry.

The conundrum of traditional drug discovery: Historically, drug discovery was a time-consuming and resource-intensive process involving countless experiments and screenings of chemical compounds. However, pharmacoinformatics emerged as a solution to this challenge, leveraging computational approaches to streamline drug discovery pipelines and enhance the probability of success.

Pharmacoinformatics unveiled pharmacoinformatics is the intersection of pharmacology, chemistry, and computer science. It encompasses a range of computational techniques aimed at accelerating various stages of drug discovery, from target identification and compound screening to optimization and clinical trials.